Fit to Scale · GTM for founder-led B2B SaaS
Your intuition closes deals. The problem is that only your intuition closes deals.
Founder-led sales is a feature early and a ceiling later. Growth breaks the moment a deal needs to move without you in the room. Fit to Scale converts what you do instinctively into a documented system your team can run — so the next deal doesn't depend on your calendar.
Early traction comes from founder vision, trust in the founder, and the founder's network. That works surprisingly long — until your team has to close without founder status, cold leads have to understand the business case without friction, and buyers have to justify the spend internally.
What looks like an activity problem is almost always poor alignment across the sales levers. 'Qualified' deals stall late because the business case was never real. Pricing becomes a discussion because the value chain isn't clear. Marketing and sales blame each other because the funnel runs on different assumptions.
Most founders already know what needs work. The problem isn't awareness — it's focus and completion. Progress happens in fragments (a few features, a better deck, more outreach) but nothing fundamentally changes, because a partial system doesn't scale. The six blocks have to lock together:
Who you reliably win, and why you, said in the buyer's words.
The one outcome the product must deliver to matter.
The quantified reason to buy, and to buy now.
How you separate real deals from polite interest before they clog the pipeline.
How price maps to value so it stops being the conversation.
The story a non-founder can tell and a buyer can repeat internally.
Across AI/media, health tech and insurance SaaS, the same move — align the system, then scale it — produced investment, pipeline and closed ARR.
Situation. Founder-led selling proved strong demand, but the hired sales team couldn't convert — active pipeline, no closes, no structure or tracking.
Move. We located the pipeline breakpoints, rebuilt the sales narrative around clear ROI, and installed structured targets and tracking.
Result. From zero to multiple closed deals in 3 months; a full, progressing pipeline.
Situation. Post-crisis team running three products across B2C and B2B; founder-driven, opportunistic sales; no clear ICP or value proposition.
Move. We defined a sharp ICP, shut down the B2C line, and merged two products into one focused offering.
Result. €2.5M new investment secured, merger with a competitor, €2M pipeline generated, €600K ARR closed.
Situation. Highly customised sales software requiring per-client hardware adaptation; slow time-to-market, only large projects viable, hard to close without traction.
Move. We shifted from custom builds to a browser-based SaaS product with limited customisation and a scalable subscription model.
Result. First €200K client closed in 3 months; entry into larger, reputable insurance accounts.
The 10-week program rebuilds and validates the system before you scale it. The goal is not to look scalable. The goal is to become scalable.
We do not promise:
We deliver:
The goal is not to look scalable — the goal is to become scalable.
The 10-week Fit-to-Scale program is not a pitch call. It's a structured analysis of where your pipeline breaks, a layout of how to fix the misalignment, and a system to scale sales. If there's no fit, I'll tell you directly.
Build my sales engine
Dr. Denis Jung
Founder, Fit to Scale
Fix the PipelineOne more thing
A short breakdown of why — and how to fix it.
Build my sales engine